71002-67-0 Usage
Uses
Used in Agricultural Industry:
1-(butoxy-ethyl-phosphoryl)oxy-4-nitro-benzene is used as a pesticide for controlling a broad spectrum of pests and insects that can damage crops and reduce agricultural productivity. Its application helps protect plants from harmful insects, thereby ensuring a healthy and sustainable yield.
Used in Industrial Settings:
In industrial settings, 1-(butoxy-ethyl-phosphoryl)oxy-4-nitro-benzene is utilized as an insecticide to manage insect infestations that can cause structural damage or pose health risks. Its application in this context aids in maintaining cleanliness and safety within industrial facilities.
It is crucial to handle 1-(butoxy-ethyl-phosphoryl)oxy-4-nitro-benzene with care, as it can be harmful if inhaled or ingested. Therefore, proper safety measures and precautions should be taken when using or handling this chemical to minimize any potential adverse effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 71002-67-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,0,0 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 71002-67:
(7*7)+(6*1)+(5*0)+(4*0)+(3*2)+(2*6)+(1*7)=80
80 % 10 = 0
So 71002-67-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H18NO5P/c1-3-5-10-17-19(16,4-2)18-12-8-6-11(7-9-12)13(14)15/h6-9H,3-5,10H2,1-2H3
71002-67-0Relevant academic research and scientific papers
Butyrylcholinesterase Inhibitors
-
Paragraph 0127, (2016/08/17)
Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated
BUTYRYLCHOLINESTERASE INHIBITORS
-
, (2010/04/23)
Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
